CA Stock MarketDetailed Quotes

CSCI Cosciens Biopharma Inc

Watchlist
  • 4.710
  • -0.190-3.88%
15min DelayTrading Apr 30 13:18 ET
14.82MMarket Cap-0.55P/E (TTM)

Cosciens Biopharma Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
34.22%9.59M
173.64%3.32M
-4.15%1.87M
67.89%2.34M
-20.55%2.05M
-50.98%7.14M
-62.36%1.21M
-30.58%1.95M
-67.39%1.39M
-47.73%2.58M
Operating revenue
34.22%9.59M
173.64%3.32M
-4.15%1.87M
67.89%2.34M
-20.55%2.05M
-50.98%7.14M
-62.36%1.21M
-30.58%1.95M
-67.39%1.39M
-47.73%2.58M
Cost of revenue
15.53%4.86M
19.42%1.27M
-20.31%914K
155.13%1.52M
-17.57%1.15M
-30.10%4.21M
-42.23%1.07M
-0.25%1.15M
-54.20%595K
-29.04%1.4M
Gross profit
60.96%4.73M
1,284.46%2.05M
18.88%957K
2.76%819K
-24.05%901.72K
-65.66%2.94M
-89.28%148K
-51.56%805K
-73.16%797K
-60.10%1.19M
Operating expense
147.81%18.75M
159.11%5.66M
202.24%5.79M
139.35%4.57M
74.52%2.71M
78.64%7.57M
61.32%2.18M
120.28%1.92M
51.77%1.91M
71.86%1.56M
Selling and administrative expenses
89.04%10.45M
62.01%2.75M
102.16%2.99M
149.51%3.04M
46.21%1.65M
92.91%5.53M
94.80%1.7M
131.25%1.48M
45.76%1.22M
82.33%1.13M
-Selling and marketing expense
----
----
----
----
-44.20%3.37K
----
----
----
----
42.47%6.05K
-General and administrative expense
89.04%10.45M
62.01%2.75M
102.16%2.99M
----
46.69%1.65M
92.91%5.53M
91.47%1.7M
132.88%1.48M
----
82.60%1.12M
Research and development costs
307.06%8.3M
495.71%2.91M
541.97%2.8M
121.42%1.53M
150.02%1.06M
48.80%2.04M
1.10%489K
89.74%436K
63.69%691K
49.04%424.14K
Operating profit
-202.94%-14.02M
-77.31%-3.61M
-335.10%-4.83M
-237.07%-3.76M
-392.70%-1.81M
-207.15%-4.63M
-7,861.24%-2.04M
-240.25%-1.11M
-165.13%-1.11M
-117.76%-367.79K
Net non-operating interest income (expenses)
505.19%312K
1,061.11%418K
4.35%-22K
8.33%-22K
4.84%-62.48K
-3,950.00%-77K
-68.10%36K
-0.23%-23K
3.89%-24K
6.90%-65.65K
Non-operating interest income
647.46%441K
----
----
----
----
-59.31%59K
----
----
----
----
Non-operating interest expense
-5.15%129K
0.00%23K
-4.35%22K
-8.33%22K
-12.87%21.77K
-4.90%136K
-68.22%23K
0.23%23K
-3.89%24K
-5.56%24.99K
Total other finance cost
----
----
----
----
0.10%40.7K
----
----
----
----
-7.70%40.66K
Other net income (expenses)
-550.60%-1.51M
-3,332.89%-2.46M
-792.47%-1.01M
4,274.42%1.88M
-9.51%64.14K
63.11%336K
278.45%76K
-26.37%146K
-71.12%43K
171.92%70.88K
Gain on sale of security
11,120.83%2.65M
--632K
--217K
--1.77M
231.11%24.6K
-111.37%-24K
----
----
----
78.06%-18.77K
Special income (charges)
---4.26M
---2.8M
---1.46M
----
----
--0
--0
--0
----
----
-Less:Impairment of capital assets
--4.26M
--2.8M
--1.46M
----
----
--0
--0
--0
----
----
Other non-operating income (expenses)
-72.78%98K
-391.00%-291K
58.22%231K
153.49%109K
-55.90%39.53K
7,300.00%360K
4,678.24%100K
891.59%146K
507.52%43K
789.18%89.65K
Income before tax
-248.40%-15.23M
-193.61%-5.65M
-493.83%-5.87M
-73.15%-1.9M
-399.35%-1.81M
-196.51%-4.37M
-2,093.97%-1.92M
-202.12%-988K
-159.70%-1.1M
-119.07%-362.56K
Income tax
109.49%84K
400.56%1.08M
47.17%-112K
-101.70%-474K
-428.39%-411.54K
-181.94%-885K
-1,193.93%-360K
-192.74%-212K
-154.22%-235K
-117.34%-77.89K
Earnings from equity interest net of tax
Net income
-339.28%-15.31M
-330.37%-6.73M
-641.62%-5.76M
-65.35%-1.42M
-391.40%-1.4M
-201.07%-3.49M
-2,559.81%-1.56M
-205.02%-776K
-161.39%-860K
-119.60%-284.67K
Net income continuous operations
-339.28%-15.31M
-330.37%-6.73M
-641.62%-5.76M
-65.35%-1.42M
-391.40%-1.4M
-201.07%-3.49M
-2,559.81%-1.56M
-205.02%-776K
-161.39%-860K
-119.60%-284.67K
Noncontrolling interests
Net income attributable to the company
-339.28%-15.31M
-330.37%-6.73M
-641.62%-5.76M
-65.35%-1.42M
-391.40%-1.4M
-201.07%-3.49M
-2,559.81%-1.56M
-205.02%-776K
-161.39%-860K
-119.60%-284.67K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-339.28%-15.31M
-330.37%-6.73M
-641.62%-5.76M
-65.35%-1.42M
-391.40%-1.4M
-201.07%-3.49M
-2,559.81%-1.56M
-205.02%-776K
-161.39%-860K
-119.60%-284.67K
Diluted earnings per share
-213.76%-5.93
-176.47%-2.35
-340.48%-1.85
-36.17%-0.64
-306.87%-0.6272
-201.07%-1.89
-7,848.40%-0.85
-235.55%-0.42
-171.46%-0.47
-122.71%-0.1541
Basic earnings per share
-213.76%-5.93
-176.47%-2.35
-340.48%-1.85
-36.17%-0.64
-306.87%-0.6272
-201.61%-1.89
-87,728.87%-0.85
-235.55%-0.42
-171.46%-0.47
-122.71%-0.1541
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 34.22%9.59M173.64%3.32M-4.15%1.87M67.89%2.34M-20.55%2.05M-50.98%7.14M-62.36%1.21M-30.58%1.95M-67.39%1.39M-47.73%2.58M
Operating revenue 34.22%9.59M173.64%3.32M-4.15%1.87M67.89%2.34M-20.55%2.05M-50.98%7.14M-62.36%1.21M-30.58%1.95M-67.39%1.39M-47.73%2.58M
Cost of revenue 15.53%4.86M19.42%1.27M-20.31%914K155.13%1.52M-17.57%1.15M-30.10%4.21M-42.23%1.07M-0.25%1.15M-54.20%595K-29.04%1.4M
Gross profit 60.96%4.73M1,284.46%2.05M18.88%957K2.76%819K-24.05%901.72K-65.66%2.94M-89.28%148K-51.56%805K-73.16%797K-60.10%1.19M
Operating expense 147.81%18.75M159.11%5.66M202.24%5.79M139.35%4.57M74.52%2.71M78.64%7.57M61.32%2.18M120.28%1.92M51.77%1.91M71.86%1.56M
Selling and administrative expenses 89.04%10.45M62.01%2.75M102.16%2.99M149.51%3.04M46.21%1.65M92.91%5.53M94.80%1.7M131.25%1.48M45.76%1.22M82.33%1.13M
-Selling and marketing expense -----------------44.20%3.37K----------------42.47%6.05K
-General and administrative expense 89.04%10.45M62.01%2.75M102.16%2.99M----46.69%1.65M92.91%5.53M91.47%1.7M132.88%1.48M----82.60%1.12M
Research and development costs 307.06%8.3M495.71%2.91M541.97%2.8M121.42%1.53M150.02%1.06M48.80%2.04M1.10%489K89.74%436K63.69%691K49.04%424.14K
Operating profit -202.94%-14.02M-77.31%-3.61M-335.10%-4.83M-237.07%-3.76M-392.70%-1.81M-207.15%-4.63M-7,861.24%-2.04M-240.25%-1.11M-165.13%-1.11M-117.76%-367.79K
Net non-operating interest income (expenses) 505.19%312K1,061.11%418K4.35%-22K8.33%-22K4.84%-62.48K-3,950.00%-77K-68.10%36K-0.23%-23K3.89%-24K6.90%-65.65K
Non-operating interest income 647.46%441K-----------------59.31%59K----------------
Non-operating interest expense -5.15%129K0.00%23K-4.35%22K-8.33%22K-12.87%21.77K-4.90%136K-68.22%23K0.23%23K-3.89%24K-5.56%24.99K
Total other finance cost ----------------0.10%40.7K-----------------7.70%40.66K
Other net income (expenses) -550.60%-1.51M-3,332.89%-2.46M-792.47%-1.01M4,274.42%1.88M-9.51%64.14K63.11%336K278.45%76K-26.37%146K-71.12%43K171.92%70.88K
Gain on sale of security 11,120.83%2.65M--632K--217K--1.77M231.11%24.6K-111.37%-24K------------78.06%-18.77K
Special income (charges) ---4.26M---2.8M---1.46M----------0--0--0--------
-Less:Impairment of capital assets --4.26M--2.8M--1.46M----------0--0--0--------
Other non-operating income (expenses) -72.78%98K-391.00%-291K58.22%231K153.49%109K-55.90%39.53K7,300.00%360K4,678.24%100K891.59%146K507.52%43K789.18%89.65K
Income before tax -248.40%-15.23M-193.61%-5.65M-493.83%-5.87M-73.15%-1.9M-399.35%-1.81M-196.51%-4.37M-2,093.97%-1.92M-202.12%-988K-159.70%-1.1M-119.07%-362.56K
Income tax 109.49%84K400.56%1.08M47.17%-112K-101.70%-474K-428.39%-411.54K-181.94%-885K-1,193.93%-360K-192.74%-212K-154.22%-235K-117.34%-77.89K
Earnings from equity interest net of tax
Net income -339.28%-15.31M-330.37%-6.73M-641.62%-5.76M-65.35%-1.42M-391.40%-1.4M-201.07%-3.49M-2,559.81%-1.56M-205.02%-776K-161.39%-860K-119.60%-284.67K
Net income continuous operations -339.28%-15.31M-330.37%-6.73M-641.62%-5.76M-65.35%-1.42M-391.40%-1.4M-201.07%-3.49M-2,559.81%-1.56M-205.02%-776K-161.39%-860K-119.60%-284.67K
Noncontrolling interests
Net income attributable to the company -339.28%-15.31M-330.37%-6.73M-641.62%-5.76M-65.35%-1.42M-391.40%-1.4M-201.07%-3.49M-2,559.81%-1.56M-205.02%-776K-161.39%-860K-119.60%-284.67K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -339.28%-15.31M-330.37%-6.73M-641.62%-5.76M-65.35%-1.42M-391.40%-1.4M-201.07%-3.49M-2,559.81%-1.56M-205.02%-776K-161.39%-860K-119.60%-284.67K
Diluted earnings per share -213.76%-5.93-176.47%-2.35-340.48%-1.85-36.17%-0.64-306.87%-0.6272-201.07%-1.89-7,848.40%-0.85-235.55%-0.42-171.46%-0.47-122.71%-0.1541
Basic earnings per share -213.76%-5.93-176.47%-2.35-340.48%-1.85-36.17%-0.64-306.87%-0.6272-201.61%-1.89-87,728.87%-0.85-235.55%-0.42-171.46%-0.47-122.71%-0.1541
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More